Integrated Filing — IndAS



General information about company
Scrip Code 500201
NSE Symbol INDIAGLYCO
MSEI Symbol NOTLISTED
ISIN INE560A01015
Name of company INDIA GLYCOLS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Date of board meeting when results were approved 07-Aug-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 31-Jul-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 07-Aug-2025   15:47:00
End date and time of board meeting 07-Aug-2025   17:00:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party?
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.
Whether the company is a high value debt listed entity according to regulation 15 (1A)?
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?
Latest Date on which RPT policy is updated
Indicate Company website link for updated RPT policy of the Company
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
During the Quarter Company has not made any default on Loans and Debt securities.



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 25030300000
Other income 14000000
Total income 25044300000
2 Expenses
(a) Cost of materials consumed 6691000000
(b) Purchases of stock-in-trade 441900000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -359700000
(d) Employee benefit expense 306000000
(e) Finance costs 446800000
(f) Depreciation, depletion and amortisation expense 344500000
(f) Other Expenses
1 Excise Duty 14626600000 14626600000
2 Power and Fuel 915300000 915300000
3 Other Expenses 930600000 930600000
Total other expenses 16472500000
Total expenses 24343000000
3 Total profit before exceptional items and tax 701300000
4 Exceptional items 0
5 Total profit before tax 701300000
6 Tax expense
7 Current tax 75700000
8 Deferred tax 97100000
9 Total tax expenses 172800000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0
11 Net Profit Loss for the period from continuing operations 528500000
12 Profit (loss) from discontinued operations before tax 0
13 Tax expense of discontinued operations 0
14 Net profit (loss) from discontinued operation after tax 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0
16 Total profit (loss) for period 528500000
17 Other comprehensive income net of taxes -1900000
18 Total Comprehensive Income for the period 526600000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 309600000
Face value of equity share capital 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 17.07
Diluted earnings (loss) per share from continuing operations 17.07
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0
Diluted earnings (loss) per share from discontinued operations 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 17.07
Diluted earnings (loss) per share from continuing and discontinued operations 17.07
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results
Textual Information(1) Note on Financial Results: nNote: At point no.21 'Face value of equity share capital' of Rs.10 is the Face value per equity share.



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2025
Date of end of reporting period 30-Jun-2025
Whether accounts are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Bio-based Specialities and Performance Chemicals 2999000000 2999000000
2 Potable Spirits 18050600000 18050600000
3 Ennature Biopharma 505000000 505000000
4 Bio-Fuel 3475700000 3475700000
Total Segment Revenue 25030300000
Less: Inter segment revenue 0 0
Revenue from operations 25030300000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Bio-based Specialities and Performance Chemicals 308200000 308200000
2 Potable Spirits 723300000 723300000
3 Ennature Biopharma 12000000 12000000
4 Bio-Fuel 226700000 226700000
Total Profit before tax 1270200000
i. Finance cost 446800000 446800000
ii. Other Unallocable Expenditure net off Unallocable income 122100000 122100000
Profit before tax 701300000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Bio-based Specialities and Performance Chemicals 34354800000 34354800000
2 Potable Spirits 6013200000 6013200000
3 Ennature Biopharma 4515000000 4515000000
4 Bio-Fuel 12455600000 12455600000
Total Segment Asset 57338600000 57338600000
Un-allocable Assets 1042100000 1042100000
Net Segment Asset 58380700000 58380700000
4 Segment Liabilities
Segment Liabilities
1 Bio-based Specialities and Performance Chemicals 7668700000 7668700000
2 Potable Spirits 3392500000 3392500000
3 Ennature Biopharma 728400000 728400000
4 Bio-Fuel 935900000 935900000
Total Segment Liabilities 12725500000 12725500000
Un-allocable Liabilities 26418100000 26418100000
Net Segment Liabilities 39143600000 39143600000
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit and loss -2500000 -2500000
Total Amount of items that will not be reclassified to profit and loss -2500000
2 Income tax relating to items that will not be reclassified to profit or loss -600000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0
5 Total Other comprehensive income -1900000